Gregory S. Zaric, Ph.D.
Affiliations: | 2000 | Stanford University, Palo Alto, CA |
Area:
Operations Research, Health Care ManagementGoogle:
"Gregory Zaric"Parents
Sign in to add mentor| Margaret L. Brandeau | grad student | 2000 | Stanford | |
| (Resource allocation for epidemic control.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Hannouf MB, Zaric GS, Blanchette P, et al. (2019) Cost-effectiveness analysis of multigene expression profiling assays to guide adjuvant therapy decisions in women with invasive early-stage breast cancer. The Pharmacogenomics Journal |
| Qu M, Chen Y, Zaric G, et al. (2019) Is SABR Cost-Effective in Oligometastatic Cancer? An Economic Analysis of SABR-Comet International Journal of Radiation Oncology*Biology*Physics. 105: S100-S101 |
| Hannouf M, Zaric G, Brackstone M. (2018) Abstract P4-12-05: Cost-effectiveness analysis of second-generation multi-gene expression prognostic assays compared with the standard 21-gene recurrence score assay to guide adjuvant therapy decisions in women with early stage breast cancer Cancer Research. 78 |
| Mahjoub R, Ødegaard F, Zaric GS. (2017) Evaluation of a pharmaceutical risk-sharing agreement when patients are screened for the probability of success. Health Economics |
| Ghamat S, Zaric GS, Pun H. (2017) Contracts to Promote Optimal Use of Optional Diagnostic Tests in Cancer Treatment Production and Operations Management. 27: 2184-2200 |
| Hannouf MB, Winquist E, Mahmud SM, et al. (2016) Cost-effectiveness of using a gene expression profiling test to aid in identifying the primary tumour in patients with cancer of unknown primary. The Pharmacogenomics Journal |
| Zaric GS. (2016) Cost Implications of Value-Based Pricing for Companion Diagnostic Tests in Precision Medicine. Pharmacoeconomics |
| Nguyen TK, Goodman CD, Boldt RG, et al. (2015) Evaluation of Health Economics in Radiation Oncology: A Systematic Review. International Journal of Radiation Oncology, Biology, Physics |
| Enns EA, Zaric GS, Strike CJ, et al. (2015) Potential cost-effectiveness of supervised injection facilities in Toronto and Ottawa, Canada. Addiction (Abingdon, England) |
| Zhang H, Zaric GS. (2015) Using price-volume agreements to manage pharmaceutical leakage and off-label promotion. The European Journal of Health Economics : Hepac : Health Economics in Prevention and Care. 16: 747-61 |